WELIREG is the first and only oral hypoxia-inducible factor-2 alpha inhibitor approved in the European Union RAHWAY, N.J. — (BUSINESS WIRE) — $MRK #MRK — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, on Tuesday
BETHESDA, Md. — (BUSINESS WIRE) — Curator Hotel & Resort Collection proudly announces that eight of its distinguished member properties have been recognized in the prestigious Forbes Travel Guide 2025 Star Award rankings, a globally respected benchmark for excellence in hospitality.
Straight Talk Wireless shows the power of unlimited data by putting extra money in people’s pockets during this taxing time. NEW YORK — (BUSINESS WIRE) — Straight Talk Wireless, a leading prepaid brand covered by Verizon’s 5G network and
MOORESTOWN, N.J. — (BUSINESS WIRE) — OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, is introducing significant enhancements to its Infinity® Automated Storage and Retrieval System (AS/RS). Enhanced features include a 15
SAN DIEGO — (BUSINESS WIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that the Alarum Technologies class action lawsuit seeks to represent purchasers or acquirers of Alarum Technologies Ltd. (NASDAQ: ALAR) securities between March 14, 2024 and
No new safety signals observed at Year 5 in the POETYK PSO long-term extension trial, consistent with the established Sotyktu safety profile Following five years of continuous Sotyktu treatment, clinical response was maintained in nearly half of patients for Psoriasis Area and
— (PITCH PR) — Talent assessments aren’t new. Most companies already use them — in fact, 80% of Fortune 500 companies rely on them. Unfortunately, many of them do not have a clearly defined strategy in place for their use.
Results presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium (ASCO GU 2025) Treatment with UGN-102 resulted in durable complete response (CR) rates across subgroups with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) CR rates were: 82.8% for patients
PARSIPPANY, N.J. — (BUSINESS WIRE) — B&G Foods, Inc. (NYSE: BGS) today explained the tax treatment for dividends paid in 2024 on the Company’s common stock. Holders are urged to check their 2024 tax statements received from brokerage firms to ensure that